Pygeum (African Cherry).

Saw palmetto's lipidosterolic extract and pygeum's phytosterols contribute to the same sterol pool, with pygeum adding triterpene effects on the tissue itself. The pair has been formulated together for decades for normal prostate function.

Nettle root lignans interact with sex hormone binding globulin and aromatase, a step upstream of the sterol contribution pygeum makes. Combining them covers two different points on the same axis.

Beta-sitosterol is the main sterol carried in pygeum bark extract, so an added sterol dose contributes to the same pool. Sterol-attributed effects should be counted across both rather than separately.

Zinc concentrates in prostate tissue and acts as a cofactor in the enzymes that handle normal androgen conversion there. It is long-standing practice to supply it alongside sterol-based prostate formulas.

Lycopene accumulates preferentially in prostate tissue where it acts as a lipid-phase antioxidant, a different role from pygeum's sterol contribution. The two are combined so one formula covers both.

Selenium is the cofactor for glutathione peroxidase and the thioredoxin reductases that manage peroxide load in prostate tissue. That antioxidant layer sits alongside, not on top of, pygeum's sterol mechanism.

Quercetin stabilises mast cells and dampens local inflammatory signalling, a mechanism unrelated to pygeum's sterol and triterpene action. The two are routinely formulated together for that division of labour.

Phytosterols compete with carotenoids for space in the mixed micelles that carry both to the enterocyte. A carotenoid dosed together with a sterol-rich extract is absorbed less well, so separate the timing.

The active fraction of Prunus africana bark is a lipid extract carrying phytosterols, triterpenes and long-chain fatty alcohol esters. Compounds of this class need bile salts and dietary fat to enter mixed micelles before they cross the enterocyte. A lipid carrier in the softgel, or simply taking the capsule with a meal containing fat, is the ordinary way formulators handle that. This is absorption chemistry, not a clinical outcome measured for the pairing.

Phytosterols displace other lipophilic molecules from mixed micelles, and tocopherol is one of the fractions measured lower when sterol intake rises. The same sterol-rich extract oxidises in storage, which is why a tocopherol is often added to the oil base as an antioxidant. Those two facts pull in opposite directions and both are worth stating. Read this as pharmacology of the sterol class rather than a trial of pygeum with vitamin E.

Lutein is absorbed from the same mixed micelle that carries plant sterols. Sterol-rich intakes lower measured plasma carotenoids, which is a marker of absorption and not itself an outcome. Where a formula pairs a sterol-bearing bark extract with a carotenoid, separating the doses across the day is the usual formulation answer. No combination trial is being cited here.

Pumpkin seed oil carries its own delta-7 sterols and sits beside pygeum in many older-male botanical blends. Both are lipid extracts, so they share a vehicle and a dosing habit. The pairing is formulation convention with overlapping phytosterol chemistry rather than a tested combination. Anything stronger would need a trial of the two together.

An EPA/DHA oil base gives the bark extract the same lipid environment a fatty meal would. Formulators use it when they want one oil to serve as both an active and a vehicle. The absorption logic is settled; the clinical value of that specific pairing has not been measured. Take it as formulation chemistry.

Piperine slows glucuronidation and some CYP-mediated first-pass handling, and formulators add it to botanical blends for that reason. Whether the ferulic acid esters and sterols in pygeum are affected the same way has not been shown. The mechanism is real for other phenolics; the extension to this extract is an assumption. Marked early on purpose.

African bark preparations including Prunus africana are described in review work for antioxidant activity measured in cell-free and cellular assays. Catechins act on the same class of assays. Any additive reading is mechanistic and preclinical. Nothing here is a human outcome.